Watchlist Price Alert

Madrigal Pharmaceuticals ... (MDGL)

NASDAQ: MDGL · Real-Time Price · USD

270.47

-1.10 (-0.41%)

At close: May 28, 2025, 3:59 PM

270.70

0.09%

After-hours: May 28, 2025, 05:18 PM EDT

Madrigal Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	180.13M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	6.23M	527K	467K	405K	471K	112K	96K	77K	156.00
Gross Profit	173.9M	-527K	-467K	-405K	-471K	-112K	-96K	-77K	-156
Operating Income	-497.88M	-380.5M	-293.57M	-242.48M	-206.67M	-94.97M	-40.68M	-32.06M	-25.22M
Interest Income	46.65M	19.58M	2.19M	363K	4.33M	11.02M	7.67M	558K	48.3K
Pretax Income	-465.89M	-373.63M	-295.35M	-241.85M	-202.24M	-83.95M	-32.81M	-31.15M	-26.39M
Net Income	-465.89M	-373.63M	-299.31M	-241.08M	-197.44M	-72.81M	-32.81M	-31.15M	-26.39M
Selling & General & Admin	435.06M	108.15M	48.13M	37.32M	21.86M	22.65M	15.29M	7.67M	9.29M
Research & Development	236.72M	271.82M	245.44M	205.16M	184.81M	72.32M	25.39M	24.39M	15.93M
Other Expenses	n/a	n/a	n/a	273K	100K	n/a	200K	350K	n/a
Operating Expenses	671.77M	380.5M	293.57M	242.48M	206.67M	94.97M	40.68M	32.06M	25.22M
Interest Expense	14.67M	12.71M	3.96M	n/a	n/a	11.02M	7.67M	558K	1.16M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	678.01M	380.5M	293.57M	242.48M	206.67M	94.97M	40.68M	32.06M	25.22M
Income Tax Expense	n/a	n/a	3.96M	-768K	-4.8M	-11.14M	7.87M	-635K	-373
Shares Outstanding (Basic)	21.27M	18.69M	17.14M	16.54M	15.45M	15.39M	14.8M	12.24M	5.2M
Shares Outstanding (Diluted)	21.27M	18.69M	17.14M	16.54M	15.45M	15.39M	14.8M	12.24M	5.2M
EPS (Basic)	-21.9	-19.99	-17.47	-14.58	-12.78	-4.73	-2.22	-2.54	-5.07
EPS (Diluted)	-21.9	-19.99	-17.47	-14.58	-12.78	-4.73	-2.22	-2.54	-5.07
EBITDA	-450.13M	-379.97M	-293.1M	-242.08M	-206.2M	-94.86M	-40.59M	-31.98M	-22.52M
EBIT	-451.22M	-380.5M	-291.39M	-242.48M	-206.67M	-94.97M	-40.68M	-32.06M	-25.18M
Depreciation & Amortization	1.1M	527K	467K	405K	471K	112K	96K	77K	156.00